AstraZeneca said on Monday its experimental weight-loss pill, licensed from China's Eccogene, was safe and tolerable in an ...
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
Investor's Business Daily on MSN9d
Viking Tops Novo As Obesity Pill Brawl Continues; But Shares Slash Massive GainsViking Therapeutics reported promising early results for its experimental obesity pill, with increased weight loss at higher ...
In its presentation at ObesityWeek 2024 meeting in Texas, the multinational drug company AstraZeneca (NASDAQ:AZN) revealed ...
Boosts Metabolism PhenQ helps counter the natural slowdown in metabolism that occurs during menopause, making it easier to ...
Stacker on MSN13d
What are the best prescription weight loss pills?For some people, diet, and exercise are not enough to lose weight and keep it off. This is where weight loss medication, ...
4don MSN
AstraZeneca and Viking Therapeutics both presented encouraging data on their obesity pills. Meanwhile, here’s how Americans ...
Here are the key points about Viking Therapeutics' oral obesity drug VK2735: Early-Stage Trial Results: All doses of VK2735 ...
AstraZeneca Plc said its experimental obesity pill was well-tolerated by patients with type-2 diabetes as it presented data from several studies testing its three new weight-loss medicines.
Effectiveness and safety data from Viking’s study, released Sunday at an industry conference, show that an obesity pill could ...
MarketWatch on MSN11d
Hoping for a weight-loss pill? It could get closer to reality next week.Viking Therapeutics Inc.’s stock was up up as much as 3.8% early Friday as excitement continued to build about data on the ...
Obesity pill data released by Viking Therapeutics Inc and AstraZeneca Plc at a big conference foreshadowed an increasingly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback